Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingPhase 1IIT A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending and Multiple Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of Inhaled SUN-001 in Healthy Volunteers
100 Clinical Results associated with Sunterra Bio, Inc.
0 Patents (Medical) associated with Sunterra Bio, Inc.
100 Deals associated with Sunterra Bio, Inc.
100 Translational Medicine associated with Sunterra Bio, Inc.